Showing results (471-480 of 608) with videos related to

Sort By:
Pageof 61
Leukemia Research|July 29, 2008
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemiaTait D Shanafelt, Deborah A Bowen, Chaya Venkat, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2011
Host and viral ecology determine bat rabies seasonality and maintenanceDylan B George, Colleen T Webb, Matthew L Farnsworth, et al.
British Journal of Haematology|September 10, 2011
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivoElizabeth Ward, Nanette Mittereder, Ellen Kuta, et al.
Genes, Chromosomes & Cancer|June 24, 1999
Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemiaL J Coignet, C S Lima, T Min, et al.
Cancer|December 18, 2008
Validation of a new prognostic index for patients with chronic lymphocytic leukemiaTait D Shanafelt, Greg Jenkins, Timothy G Call, et al.
Leukemia & Lymphoma|March 23, 2010
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisoneDeborah A Bowen, Timothy G Call, Tait D Shanafelt, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|July 19, 2011
Variable phenotype in murine transverse aortic constrictionSelma F Mohammed, Jimmy R Storlie, Elise A Oehler, et al.
Leukemia & Lymphoma|May 26, 2010
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemiaTait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancerPat Gulhati, Qingsong Cai, Jing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 22, 2015
Reprint of: Nitric oxide-releasing polysaccharide derivative exhibits 8-log reduction against Escherichia coli, Acinetobacter baumannii and Staphylococcus aureusAdoracion Pegalajar-Jurado, Kathryn A Wold, Jessica M Joslin, et al.
Pageof 61